what are side effects of glp 1 drugs GLP-1 Receptor Agonists what are the side effects
Description
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial

It has recently been reported that human GLP-1 analogues were more effective in reducing the occurrence of major adverse cardiovascular events, myocardial infarctions, and hospitalizations due to cardiovascular causes when compared to exendin-based GLP-1RAs [71]
[DOI] [PMC free article] [PubMed] [Google Scholar] 140.Ritz-Laser B., Estreicher A., Gauthier B.R., Mamin A., Edlund H., Philippe J

Stratified management: for those with a BMI 35 kg/m 2 and significant metabolic derangement, GLP-1RAs should be integrated as a long-term management option across the reproductive life cycle

10.1016/S0024-3205(02)01637-5 [DOI] [PubMed] [Google Scholar] 46.Frerker N, Raber K, Bode F, Skripuletz T, Nave H, Klemann C, et al

Practical Advice on Switching Between GLP-1 Receptor Agonists The recommendations discussed here are largely based on the clinical experience of the authors and are summarized in Figure 2
